AI assistant
Dechra Pharmaceuticals PLC Board/Management Information 2023
4797_mang_2023-11-29_cf9be7a3-e83b-45c6-a029-129a46fa1d08.html
Board/Management Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 0573V
Dechra Pharmaceuticals PLC
29 November 2023
29 November 2023
Dechra® Pharmaceuticals PLC
(Dechra or the Company)
LEI: 213800J4UVB5OWG8VX82
DIRECTOR DECLARATION
In accordance with Listing Rule 9.6.14(2) Dechra announces that Alison Platt, Non-Executive Chair of Dechra, has been appointed as a Chair of the Board and Non-Executive Director of Hargreaves Lansdown plc in early 2024.
For further information, please contact:
Dechra Pharmaceuticals PLC
Telephone number: +44 (0) 1606 814730
Email: [email protected]
About Dechra
Dechra is a global veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. For more information, please visit: www.dechra.com.
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RDNBLBPTMTBTMBJ